Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.

Bresser PJ, Seynaeve C, Van Gool AR, Niermeijer MF, Duivenvoorden HJ, van Dooren S, van Geel AN, Menke-Pluijmers MB, Klijn JG, Tibben A.

Eur J Cancer. 2007 Jan;43(1):95-103. Epub 2006 Nov 13.

PMID:
17095208
2.

Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?

Bresser PJ, Van Gool AR, Seynaeve C, Duivenvoorden HJ, Niermeijer MF, van Geel AN, Menke M, Klijn JG, Tibben A.

Ann Oncol. 2007 Oct;18(10):1641-5. Epub 2007 Jul 28.

PMID:
17660493
3.

Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.

Dowdy SC, Stefanek M, Hartmann LC.

Am J Obstet Gynecol. 2004 Oct;191(4):1113-23.

PMID:
15507929
4.

Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene.

Finch A, Metcalfe K, Lui J, Springate C, Demsky R, Armel S, Rosen B, Murphy J, Elit L, Sun P, Narod S.

Clin Genet. 2009 Mar;75(3):220-4.

PMID:
19263514
5.

A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.

Michelsen TM, Dørum A, Dahl AA.

Gynecol Oncol. 2009 Apr;113(1):128-33. doi: 10.1016/j.ygyno.2008.12.024. Epub 2009 Jan 29. Review.

PMID:
19178933
6.

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.

Cancer. 2006 Dec 15;107(12):2745-51.

7.

Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.

Geirdal AØ, Reichelt JG, Dahl AA, Heimdal K, Maehle L, Stormorken A, Møller P.

Fam Cancer. 2005;4(2):121-6.

PMID:
15951962
8.

Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.

Tiller K, Meiser B, Butow P, Clifton M, Thewes B, Friedlander M, Tucker K.

Gynecol Oncol. 2002 Aug;86(2):212-9.

PMID:
12144830
9.

The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.

Finch A, Metcalfe KA, Chiang J, Elit L, McLaughlin J, Springate C, Esplen MJ, Demsky R, Murphy J, Rosen B, Narod SA.

Psychooncology. 2013 Jan;22(1):212-9. doi: 10.1002/pon.2041. Epub 2011 Sep 13.

PMID:
21913283
10.

Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.

Wagner TM, Möslinger R, Langbauer G, Ahner R, Fleischmann E, Auterith A, Friedmann A, Helbich T, Zielinski C, Pittermann E, Seifert M, Oefner P.

Br J Cancer. 2000 Apr;82(7):1249-53.

11.

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.

Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.

Am J Obstet Gynecol. 2006 Jun;194(6):1702-9.

PMID:
16731090
12.

Prophylactic oophorectomy in women at increased cancer risk.

Domchek SM, Rebbeck TR.

Curr Opin Obstet Gynecol. 2007 Feb;19(1):27-30. Review.

PMID:
17218848
13.

Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer.

Meiser B, Tiller K, Gleeson MA, Andrews L, Robertson G, Tucker KM.

Psychooncology. 2000 Nov-Dec;9(6):496-503.

PMID:
11180584
14.

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.

Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Lindén A, von Wachenfeldt A, Wickman M, Arver B.

J Clin Oncol. 2008 Aug 20;26(24):3943-9. doi: 10.1200/JCO.2007.13.9568.

PMID:
18711183
15.

Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.

Michelsen TM, Dørum A, Tropé CG, Fosså SD, Dahl AA.

Int J Gynecol Cancer. 2009 Aug;19(6):1029-36. doi: 10.1111/IGC.0b013e3181a83cd5.

PMID:
19820364
16.

Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning.

Trask PC, Paterson AG, Wang C, Hayasaka S, Milliron KJ, Blumberg LR, Gonzalez R, Murray S, Merajver SD.

Psychooncology. 2001 Sep-Oct;10(5):349-60.

17.

Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

De Leeuw JR, van Vliet MJ, Ausems MG.

Fam Cancer. 2008;7(4):347-59. doi: 10.1007/s10689-008-9189-5. Epub 2008 Mar 14. Review.

PMID:
18338239
18.

Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy.

Brandberg Y, Arver B, Lindblom A, Sandelin K, Wickman M, Hall P.

Eur J Cancer. 2004 Feb;40(3):365-74.

PMID:
14746854
19.

Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.

Madalinska JB, van Beurden M, Bleiker EM, Valdimarsdottir HB, Lubsen-Brandsma L, Massuger LF, Mourits MJ, Gaarenstroom KN, van Dorst EB, van der Putten H, Boonstra H, Aaronson NK.

J Clin Oncol. 2007 Jan 20;25(3):301-7.

PMID:
17235045
20.

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.

Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mourits MJ, Verheijen RH, van Dorst EB, van der Putten H, van der Velden K, Boonstra H, Aaronson NK.

J Clin Oncol. 2005 Oct 1;23(28):6890-8. Epub 2005 Aug 29.

PMID:
16129845

Supplemental Content

Support Center